Preventing blood clots after cancer surgery: a program trial
Part of Cancer, Heart & circulation, Lungs & breathing clinical trials.
This trial tests a program to help people who had cancer surgery get medicine to prevent dangerous blood clots. If you had belly or pelvic cancer surgery and are not on blood thinners, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for cancer in your belly or pelvis (like removing part of the bowel, bladder, kidney, or uterus).
- You were not on blood thinner medicine in the month before surgery.
- You did not start blood thinner medicine after surgery.
- You do not have advanced kidney disease (stage 3 or higher).
- Your hospital stay after surgery was less than 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This trial studies how often blood clots form in catheters after major surgery, comparing patients with and without cancer. It may help doctors prevent clotting in the future.
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.